This inventor holds 138 USPTO granted patents and 86 published patent applications, plus 8 CIPO patents and 49 EPO patents, primarily in Pulmonary Hypertension (CPC class C07K2319-30). Top assignees: Acceleron Pharma Inc., Genetics Institute, Inc., Adimab, LLC. Active years: 1998-2026.
Inventors with similar research interests:
Location History:
- Shrewsbury, MA (US) (2009 - 2010)
- Houston, TX (US) (2011)
- Belmont, MA (US) (1998 - 2012)
- Acton, MA (US) (2006 - 2024)
- Cambridge, MA (US) (2019 - 2024)
Company Filing History:
120 out of 172 
13 out of 392 
2 out of 52 
Years Active: 1998-2026
Areas of Expertise:
Title: Ravindra Kumar: Innovating for a Better World
Introduction:
Ravindra Kumar, a brilliant mind hailing from Acton, MA, is an esteemed inventor and patent holder with an impressive portfolio of 114 patents. His groundbreaking inventions have contributed significantly to the fields of healthcare and biotechnology. This article delves into Kumar's latest patents, career highlights, collaborations, and his enduring commitment to innovation.
Latest Patents:
Kumar's recent patents demonstrate his deep understanding of complex biological systems and his dedication to improving human health. One such patent is titled "ALK7:ActRIIB Heteromultimers and Uses Thereof." This invention showcases soluble heteromeric polypeptide complexes that comprise the extracellular domain of an ALK7 receptor combined with the extracellular domain of ActRIIB. These heteromultimers have the potential to ameliorate metabolic parameters and treat various kidney-associated diseases.
Another remarkable patent attributed to Kumar is "Methods and Compositions for Increasing Red Blood Cells." This innovation offers compositions and techniques to boost red blood cell and hemoglobin levels in vertebrates. With potential implications for humans, this invention could hold great promise in treating certain blood disorders or conditions.
Career Highlights:
Throughout his career, Kumar has made substantial contributions to the biotechnology industry. He has been associated with renowned companies such as Acceleron Pharma Inc. and Genetics Institute, Inc. (now a part of Pfizer Inc.). At Acceleron Pharma Inc., he played a pivotal role in advancing groundbreaking research and development efforts in the field of biopharmaceuticals.
Collaborations:
Kumar's success could not have been possible without his collaborations with fellow visionaries in the industry. Notably, he has worked closely with individuals like Jasbir S Seehra and Asya Grinberg. These talented professionals have joined forces with Kumar to bring innovation to the forefront and make a lasting impact on society.
Conclusion:
Ravindra Kumar stands as an exemplary figure in the field of inventions and patents, with an impressive portfolio of 114 patents and a wide range of expertise in biotechnology. Through his groundbreaking innovations, such as the ALK7:ActRIIB heteromultimers and methods for increasing red blood cells, Kumar has demonstrated his unwavering commitment to advancing healthcare and improving the lives of individuals. His collaborations with esteemed colleagues further emphasize his dedication to collaboration and collective progress. As we eagerly anticipate Kumar's future inventions, it is clear that his contributions will continue to shape the landscape of innovation in the years to come.